30.65MMarket Cap-6500P/E (TTM)
0.195High0.175Low138.02KVolume0.180Open0.180Pre Close25.51KTurnover0.36052wk High0.09%Turnover Ratio157.18MShares0.13552wk Low-0.03EPS TTM30.49MFloat Cap5.000Historical HighLossP/E (Static)156.38MShs Float0.065Historical Low-0.03EPS LYR11.11%Amplitude--Dividend TTM-15.00P/B1Lot Size--Div YieldTTM
VentriPoint Diagnostics Ltd Stock Forum
There are many positive catalysts for Ventripoint. Firstly, any investment in the company is substantially de-risked given that the product is already developed with regulatory approvals and sales are already underway.
Its current valuation of USD$50 million is also small change for large players and this may result in an attractive exit strategy if an acquisition goes through.
Compare Ventripoint against its peers - the Nasdaq-listed $Nano X Imaging (NNOX.US)$ with a market cap of US$1.57 Billion. The potential is huge!
No comment yet